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Abstract
Amyotrophic lateral sclerosis (ALS) is a debilitating neuro-degenerative disorder characterized
by progressive loss of motor neurons. The etiology and molecular pathogenesis of cell death in
most sub-types of the disease are largely unknown. The best documented cause of moto-neuron
degeneration is the mutation in the superoxide dismutase-1 (SOD 1) gene, which occurs in 10%
of the familial forms of ALS. Discovery of RNA interference (RNAi), which plays an important role
in the regulation of gene expression, has proven to be a powerful tool to study the pathogenesis
and to develop innovative treatment options for hereditary diseases, including familial variants
of ALS. This review summarizes current research advances in RNAi in relation to ALS. © 2011
Bentham Science Publishers.
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